Journal of Preventive Medicine and Public Health

  • 제56권3호
  • /
  • Pages.231-237
  • /
  • 2023
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Determinant Factors of Mortality in Pre-elderly and Elderly Patients With COVID-19 in Jakarta, Indonesia

  • Thresya Febrianti (Faculty of Public Health, Universitas Muhammadiyah Jakarta) ;
  • Ngabila Salama (Provincial Health Office of Special Capital Region of Jakarta) ;
  • Inggariwati (Provincial Health Office of Special Capital Region of Jakarta) ;
  • Dwi Oktavia (Provincial Health Office of Special Capital Region of Jakarta)
  • 투고 : 2023.01.03
  • 심사 : 2023.05.04
  • 발행 : 2023.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: This study aimed to identify risk factors associated with coronavirus disease 2019 (COVID-19) mortality in pre-elderly and elderly individuals in Jakarta, Indonesia. Methods: We employed a case-control study design, utilizing secondary data from the Epidemiology Surveillance, Immunization Prevention, and Disease Control Sections of the DKI Jakarta Provincial Health Office, collected from December 2020 to January 2021. The study included 188 cases and an equal number of controls. Cases were COVID-19 patients confirmed to have died, as reported by hospitals and communities and subsequently verified by healthcare workers. Control subjects were patients who completed a 14-day isolation period and had been officially declared recovered by healthcare professionals. The dependent variable was the mortality of COVID-19 patients in the January 2021 period. The independent variables consisted of demographic data (age and sex), clinical symptoms (cough, runny nose, anosmia, diarrhea, headaches, abdominal pain, muscle pain, and nausea/vomiting), and comorbidities (hypertension, heart disease, and diabetes). Multivariate analysis was conducted using multiple logistic regression. Results: The multiple logistic regression analysis revealed several factors associated with COVID-19 fatalities in Jakarta: age of 60 years or older (odds ratio [OR], 4.84; 95% CI, 3.00 to 7.80), male (OR, 2.38; 95% CI, 2.41 to 3.68), dyspnea (OR, 3.93; 95% CI, 2.04 to 7.55), anosmia (OR, 0.13; 95% CI, 0.04 to 0.46), and heart disease (OR, 4.38; 95% CI, 1.04 to 18.46). Conclusions: The control and prevention of COVID-19 among elderly individuals require particular vigilance. When a COVID-19 case is detected within this demographic, prompt treatment and medication administration are crucial to mitigate the presenting symptoms.

키워드

과제정보

We appreciate the DKI Jakarta Provincial Health Office, Indonesia, for the permission to analyze COVID-19 surveillance data in Jakarta.

참고문헌

  1. Mirahmadizadeh A, Shamooshaki MT, Dadvar A, Moradian MJ, Aryaie M. Unemployment and COVID-19-related mortality: a historical cohort study of 50,000 COVID-19 patients in Fars, Iran. Epidemiol Health 2022;44:e2022032.
  2. COVID-19 Handling Task Force. Distribution data COVID-19; 2022 [cited 2022 Dec 22]. Available from: https://covid19.go.id/ (Indonesian).
  3. Pemprov DKI Jakarta. COVID-19 monitoring data; 2022 [cited 2022 Dec 22]. Available from: https://corona.jakarta.go.id/id/data-pemantauan.
  4. Alves VP, Casemiro FG, Araujo BG, Lima MA, Oliveira RS, Fernandes FT, et al. Factors associated with mortality among elderly people in the COVID-19 pandemic (SARS-CoV-2): a systematic review and meta-analysis. Int J Environ Res Public Health 2021;18(15):8008.
  5. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male 2020;23:1416-1424. https://doi.org/10.1080/13685538.2020.1774748
  6. Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother 2020;52(2):154-164. https://doi.org/10.3947/ic.2020.52.2.154
  7. Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study. Lancet Reg Health West Pac 2021;9:100108.
  8. Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HH, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health 2020;8(8):e1003-e1017. https://doi.org/10.1016/S2214-109X(20)30264-3
  9. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-1242. https://doi.org/10.1001/jama.2020.2648
  10. Ikmal NM, Noor M. Indonesian government policies in handling Covid-19. J Litbang Prov Jawa Tengah 2021;19(2):155-166 (Indonesian). https://doi.org/10.36762/jurnaljateng.v19i2.910
  11. Ministry of Health Republic of Indonesia. Circular letter number HK.02.01/MENKES/18/2022 regarding the prevention and control of COVID-19 cases of Omicron (B.1.1.529) [cited 2023 May 24]. Available from: https://upk.kemkes.go.id/new/suratedaran-nomor-hk0201menkes182022-tentang-pencegahandan-pengendalian-kasus-covid-19-varian-omicron--b11529 (Indonesian).
  12. Ministry of Health Republic of Indonesia. Regulation of the Minister of Health of the number 25 of 2016 concerning the National Action Plan; 2016 [cited 2023 May 24]. Available from: https://peraturan.bpk.go.id/Home/Details/113057/permenkes-no-25-tahun-2016 (Indonesian).
  13. Rozaliyani A, Savitri AI, Setianingrum F, Shelly TN, Ratnasari V, Kuswindarti R, et al. Factors associated with death in COVID-19 patients in Jakarta, Indonesia: an epidemiological study. Acta Med Indones 2020;52(3):246-254.
  14. Xu G, Ye M, Zhao J, Liu F, Ma W. New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes". Geroscience 2020;42(5):1225-1227. https://doi.org/10.1007/s11357-020-00232-x
  15. Ly TD, Zanini D, Laforge V, Arlotto S, Gentile S, Mendizabal H, et al. Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020. Int J Antimicrob Agents 2020;56(6):106219.
  16. Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020;11(1):6317.
  17. Noor FM, Islam MM. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health 2020;45(6):1270-1282. https://doi.org/10.1007/s10900-020-00920-x
  18. Hong KH, Choi JP, Hong SH, Lee J, Kwon JS, Kim SM, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax 2018;73(3):286-289. https://doi.org/10.1136/thoraxjnl-2016-209313
  19. Khalil K, Agbontaen K, McNally D, Love A, Mandalia S, Banya W, et al. Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital. J Infect 2020;81(3):e85-e89. https://doi.org/10.1016/j.jinf.2020.06.027
  20. Masyeni S, Nelwan EJ, Fatawy RM, Wibawa S, Nugraha PA, Antara J, et al. Clinical characteristics and outcomes of COVID-19 patients in Bali, Indonesia. PLoS One 2022;17(6):e0269026.
  21. Alizadehsani R, Alizadeh Sani Z, Behjati M, Roshanzamir Z, Hussain S, Abedini N, et al. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol 2021;93(4):2307-2320. https://doi.org/10.1002/jmv.26699
  22. Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China. Mech Ageing Dev 2020;188:111255.
  23. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020;146(1):110-118. https://doi.org/10.1016/j.jaci.2020.04.006
  24. Bakhshwin D, Alotaibi M, Ali AS, Althomali A, Alsuwat A, Alhamyani A, et al. Mortality predictors among COVID-19 elderly in Taif, Saudi Arabia. Infect Drug Resist 2022;15:3213-3223. https://doi.org/10.2147/IDR.S364279
  25. Dubik SD, Ahiable EK, Amegah KE, Manan A, Sampong FB, Boateng J, et al. Risk factors associated with COVID-19 morbidity and mortality at a national tertiary referral treatment centre in Ghana: a retrospective analysis. PAMJ Clin Med 2023. doi: https://doi.org/10.11604/pamj-cm.2023.11.17.35964.
  26. Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, et al. Clinical epidemiology of hospitalized patients with coronavirus disease 2019 (COVID-19) in Japan: report of the COVID-19 registry Japan. Clin Infect Dis 2021;73(11):e3677-e3689. https://doi.org/10.1093/cid/ciaa1470
  27. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481. https://doi.org/10.1016/S2213-2600(20)30079-5